GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
H

Haba Laboratories 4925.T · JPY

Consumer Staples · Tokyo Stock Exchange · 🇯🇵 Japan

Compare

1,657

+0.30%

Close of 9 Nov 2026, in JPY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Haba Laboratories

Its shares trade on Tokyo Stock Exchange under the ticker 4925.T. It has been listed since 11 June 2003. In the fiscal year to 31 March 2026, it reported revenue of ¥12.14bn and net income of ¥760.4m. At that date it held total assets of ¥12.52bn and shareholders' equity of ¥9.54bn.

HABA Laboratories, Inc. engages in the development, manufacture, and sale of natural cosmetics, quasi-drugs, and nutritional supplements. The company is headquartered in Chiyoda-Ku, Tokyo-To. The company went IPO on 2003-06-11. The firm's main business consists of the research, development, manufacture and distribution of women's and men's cosmetics. The firm offers its products by wholesale distribution to department stores and through mail order services to general customers. The company also handles wholesale distribution to retailers and wholesalers, as well as the sale of products at its own retail stores.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Consumer Staples
Industry
Personal Care Products
Listed since
11 Jun 2003
Employees
654
Website
haba.com ↗

Leadership

Pay as last reported

  • Ms. Noriko KoyanagiChairman of the Board, President, Chairman of Subsidiary, Representative Director, since 2016
  • Mr. Akihiko TakasakiDirector
  • Mr. Tomotaka MatsuiDirector
  • Mr. Mikio NishiDirector, since 2009
  • Mr. Yoshinori NishimuraDirector
  • Mr. Yamaoka TeruakiDirector
  • Ms. Yoshiko ArikawaIndependent Director
  • Ms. Nobuko KatoIndependent Director
  • Mr. Tsunekazu UmedaIndependent Director
  • Ms. Kayoko YamatoIndependent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Natural cosmetics and quasi-drugs are key products in Consumer Staples sector.
  • HABA Laboratories employs 654 full-time employees in Chiyoda-ku, Tokyo.
  • Wholesale distribution to department stores and mail order services are main sales channels.

Weaknesses

  • HABA Laboratories has no presence in the Financials sector or Real Estate industry.
  • The company's products are limited to natural cosmetics and nutritional supplements.
  • No mention of international expansion beyond Japan in business description.

Opportunities

  • Expanding into the Health Care industry could leverage existing natural product expertise.
  • Growing demand for natural products in Japan presents a market opportunity.
  • The Consumer Discretionary sector offers potential for new product lines.

Threats

  • Competition from established brands in the Consumer Staples sector is a constant threat.
  • The Japanese market's saturation in natural cosmetics could limit growth.
  • Regulatory changes in the quasi-drug industry may impact product offerings.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.